Patient - 医索

找到约 362 条结果

BEAT-SC A randomized phase lll study ofbevacizumab or placebo in combination withatezolizumab and platinum-based chemotherapy inpatients with extensive-stage small cell lung cancer

医客学院 - 会议报告集

Amivantamab and lazertinib inpatients with EGFR-mutant lungcancers and CNS disease

医客学院 - 会议报告集

Updated results from the Phase 1b2 HERKULES-3 studyERAS-007 plus encorafenib and cetuximab (Ec)inpatients (pts)with EC-naive metastatic BRAF V600Ecolorectal cancer (CRC)

医客学院 - 会议报告集

Phase l trial of hypoxia-responsive CEA CAR-T celltherapy in patients with heavily pretreated solid tumorvia intraperitoneal or intravenous transfusion

医客学院 - 会议报告集

Neoadjuvant treatment of lBl310 (anti-CTLA-4 antibody) plus sintilimab(anti-PD.1 antibody) in patients with microsatellite instabilityhighmismatchrepair-deficient colon cancer Results from a randomiz

医客学院 - 会议报告集

Liver Transplantation and chemotherapy versusChemotherapy alone in patients with definitivelyunresectable colorectal liver metastases results from aprospective multicentre ran

医客学院 - 会议报告集

A Phase 3, Randomized study of atezolizumab plus bevacizumab and chemotherapy in patients with EGFR or ALK mutated in non-small cell lung cancer (ATTLAS, KCSG-LU19-04)

医客学院

LBA61 Durvalumab (durva) after sequential chemoradiotherapy (CRT) in patients (pts) with unresectable stage III NSCLC Final analysis from PACIFIC-6

医客学院 - 会议报告集

LBA2 ALINA Efficacy and safety of adjuvant alectinib versus chemotherapy in patients with early-stage ALK non-small cell lung cancer (NSCLC)

医客学院 - 会议报告集

Tislelizumab plus chemotherapy for patients with EGFR-mutated non-squamous non-small cell lung cancer who progressed on EGFR tyrosine kinase inhibitor therapy

医客学院 - 其他

今日实时热搜